RNase H-based assays utilizing modified RNA monomers

US9644198B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9644198-B2
Application numberUS-201313959637-A
CountryUS
Kind codeB2
Filing dateAug 5, 2013
Priority dateApr 30, 2008
Publication dateMay 9, 2017
Grant dateMay 9, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention pertains to novel oligonucleotide compounds for use in various biological assays, such as nucleic acid amplification, ligation and sequencing reactions. The novel oligonucleotides comprise a ribonucleic acid domain and a blocking group at or near the 3′ end of the oligonucleotide. These compounds offer an added level of specificity previously unseen. Methods for performing nucleic acid amplification, ligation and sequencing are also provided. Additionally, kits containing the oligonucleotides are also disclosed herein.

First claim

Opening claim text (preview).

What is claimed is: 1. A hot start enzyme composition comprising an RNase H enzyme and a chemical modification to said RNase H enzyme, wherein said chemical modification reversibly inactivates said RNase H enzyme, and wherein said chemical modification is formed by reacting said RNase H enzyme with a maleic acid anhydride analog. 2. The hot start enzyme composition of claim 1 , wherein said RNase H enzyme is Pyrococcus abyssi RNase H enzyme. 3. The hot start enzyme composition of claim 2 , wherein said Pyrococcus abyssi RNase H enzyme comprises the amino acid sequence encoded by the nucleotide sequence of SEQ ID NO: 4. 4. The hot start enzyme composition of claim 1 , wherein said maleic anhydride analog is citraconic anhydride. 5. A hot start enzyme composition comprising an RNase H enzyme and an antibody bound to said RNase H enzyme, wherein said antibody reversibly inactivates said RNase H enzyme when said antibody is bound to said RNase H enzyme. 6. The hot start enzyme composition of claim 5 , wherein said RNase H enzyme is Pyrococcus abyssi RNase H enzyme. 7. The hot start enzyme composition of claim 6 , wherein said Pyrococcus abyssi RNaseH enzyme comprises the amino acid sequence encoded by the nucleotide sequence of SEQ ID NO: 4. 8. The hot start enzyme composition of claim 6 , wherein said antibody is an antibody that specifically binds said Pyrococcus abyssi RNase H enzyme.

Assignees

Inventors

Classifications

  • C12N9/96Primary

    Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates · CPC title

  • using modified primers or templates · CPC title

  • Nucleic acid amplification reactions · CPC title

  • Hot start · CPC title

  • Endonuclease · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9644198B2 cover?
The present invention pertains to novel oligonucleotide compounds for use in various biological assays, such as nucleic acid amplification, ligation and sequencing reactions. The novel oligonucleotides comprise a ribonucleic acid domain and a blocking group at or near the 3′ end of the oligonucleotide. These compounds offer an added level of specificity previously unseen. Methods for performing…
Who is the assignee on this patent?
Walder Joseph Alan, Behlke Mark Aaron, Rose Scott, and 2 more
What technology area does this patent fall under?
Primary CPC classification C12N9/96. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).